| scholarly article | Q13442814 |
| P50 | author | Fernando M. Reis | Q43130318 |
| Karina B Gomes | Q54218190 | ||
| P2093 | author name string | Ana L Candido | |
| Ana L Rocha | |||
| Flávia R Oliveira | |||
| Rosana C Azevedo | |||
| Thais M Peres | |||
| Virginia A Silva | |||
| P2860 | cites work | Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome | Q39001562 |
| Ovulation induction in polycystic ovary syndrome: Current options | Q39014747 | ||
| Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis. | Q39371422 | ||
| Habitual physical activity is associated with improved anthropometric and androgenic profile in PCOS: a cross-sectional study. | Q40414974 | ||
| Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance | Q42825169 | ||
| Clomiphene citrate combined with metformin versus letrozole for induction of ovulation in clomiphene-resistant polycystic ovary syndrome: a randomized clinical trial. | Q46538155 | ||
| Combined oral contraceptives and/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis | Q47222891 | ||
| A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome. | Q47393049 | ||
| Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. | Q47402228 | ||
| Irisin in metabolic diseases | Q47420842 | ||
| The efficacy of 24-month metformin for improving menses, hormone and metabolic profiles in polycystic ovary syndrome | Q47564976 | ||
| Polycystic ovary syndrome throughout a woman's life | Q47915318 | ||
| Metformin vs myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study. | Q48349236 | ||
| The Diagnosis of Polycystic Ovary Syndrome during Adolescence. | Q49122978 | ||
| Safety of hormonal contraception for obese women | Q49499945 | ||
| Circulating irisin in patients with polycystic ovary syndrome: a meta-analysis | Q50025261 | ||
| Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline | Q50228874 | ||
| Androgen Therapy in Women: A Reappraisal: An Endocrine Society Clinical Practice Guideline | Q22306200 | ||
| Genetic, hormonal and metabolic aspects of PCOS: an update | Q26740034 | ||
| Pregnancy complications in women with polycystic ovary syndrome | Q26822402 | ||
| Serum Vitamin D Levels and Polycystic Ovary syndrome: A Systematic Review and Meta-Analysis | Q26824831 | ||
| Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome | Q28081238 | ||
| Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome | Q28390200 | ||
| A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis | Q28588558 | ||
| CLINICAL PRACTICE. Polycystic Ovary Syndrome | Q29248890 | ||
| Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis | Q30847984 | ||
| Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline | Q33587845 | ||
| The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone. | Q34032712 | ||
| The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial | Q34036909 | ||
| Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome | Q34288567 | ||
| Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society | Q34392414 | ||
| Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis | Q34413018 | ||
| The myokine irisin increases cortical bone mass. | Q34494334 | ||
| The polycystic ovary syndrome--a medical condition but also an important psychosocial problem. | Q34506046 | ||
| Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion | Q34508533 | ||
| Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients | Q34546109 | ||
| Association between polycystic ovary syndrome and the risk of pregnancy complications: A PRISMA-compliant systematic review and meta-analysis | Q36230340 | ||
| Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis | Q37822647 | ||
| Mood and anxiety disorders in women with PCOS. | Q37969436 | ||
| Polycystic ovaries - beyond menopause | Q38124922 | ||
| Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features | Q38565775 | ||
| Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome | Q38602016 | ||
| Inositol supplementation in women with polycystic ovary syndrome undergoing intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials | Q38649843 | ||
| Comparison of myo-inositol and metformin on clinical, metabolic and genetic parameters in polycystic ovary syndrome: A randomized controlled clinical trial | Q38796542 | ||
| Effects of orlistat vs. metformin on weight loss-related clinical variables in women with PCOS: systematic review and meta-analysis | Q38844986 | ||
| The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance | Q38924361 | ||
| Effect of metformin and oral contraceptives on polycystic ovary syndrome and IVF cycles | Q38937980 | ||
| The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria? | Q39001136 | ||
| Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. | Q51300676 | ||
| Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS). | Q52841821 | ||
| Vitamin D Supplementation Decreases TGF-β1 Bioavailability in PCOS: A Randomized Placebo-Controlled Trial. | Q52908360 | ||
| The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes. | Q53146967 | ||
| Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36). | Q53250094 | ||
| The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized Trial. | Q53728238 | ||
| Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters. | Q53761370 | ||
| Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study. | Q53828381 | ||
| Regular aerobic exercise correlates with reduced anxiety and incresed levels of irisin in brain and white adipose tissue. | Q53830195 | ||
| Intravaginal administration of metformin hydrochloride loaded cationic niosomes amalgamated with thermosensitive gel for the treatment of polycystic ovary syndrome: In vitro and in vivo studies. | Q55025376 | ||
| Kisspeptin and LH pulsatile temporal coupling in PCOS patients. | Q55379865 | ||
| Myo-inositol and D-chiro-inositol (40:1) reverse histological and functional features of polycystic ovary syndrome in a mouse model | Q57467075 | ||
| Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome | Q57689237 | ||
| Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome | Q58836764 | ||
| Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria | Q60300821 | ||
| The phenotype of polycystic ovary syndrome ameliorates with aging | Q85025709 | ||
| Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease | Q86895780 | ||
| Counting ovarian follicles: updated threshold for diagnosis of hyperandrogenic anovulation | Q87493815 | ||
| Metformin Use in PCOS Pregnancies Increases the Risk of Offspring Overweight at 4 Years of Age: Follow-Up of Two RCTs | Q87909618 | ||
| An update on PCOS in adolescents | Q88755933 | ||
| The association between circulating irisin levels and different phenotypes of polycystic ovary syndrome | Q88766886 | ||
| Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer's models | Q90929504 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | polycystic ovary syndrome | Q500816 |
| insulin resistance | Q1053470 | ||
| polycystic ovary | Q5547896 | ||
| P304 | page(s) | 565 | |
| P577 | publication date | 2019-04-26 | |
| P1433 | published in | F1000Research | Q27701587 |
| P1476 | title | Recent advances in the understanding and management of polycystic ovary syndrome | |
| P478 | volume | 8 |
| Q89695680 | Adherence to treatment for polycystic ovarian syndrome: A systematic review |
| Q112285355 | Changes in Serum Cytokines Throughout Pregnancy in Women With Polycystic Ovary Syndrome |
| Q97519005 | Gonadal Hormones and Stroke Risk: PCOS as a Case Study |
Search more.